Eagle Bay Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Eagle Bay Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-96	Closed	-$12.6K	–	957
2022 Q4	$12.6K	Sell	96 -861	-90%	-$111K	0.01%	585
2022 Q3	$112K	Sell	957 -40	-4%	-$4.97K	0.07%	185
2022 Q2	$117K	Buy	+997	New	+$118K	0.07%	177
2021 Q4	–	Sell	-330	Closed	-$54K	–	1179
2021 Q3	$54K	Buy	330 +165	+100%	+$27.8K	0.03%	389
2021 Q2	$28K	Buy	+165	New	+$25.4K	0.02%	475

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eagle Bay Advisors's IBB Position: Q1 2023 in Review

Eagle Bay Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 96 shares — an estimated $12.6K sold.

Eagle Bay Advisors first reported a position in IBB in Q2 2021 and held it in 5 quarters. The position peaked at $117K in Q2 2022. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

Eagle Bay Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
Eagle Bay Advisors sold 96 iShares Biotechnology ETF shares in Q1 2023, an estimated $12.6K.
Eagle Bay Advisors first reported a position in iShares Biotechnology ETF in Q2 2021 and held it in 5 quarters.
Eagle Bay Advisors's iShares Biotechnology ETF position peaked at $117K in Q2 2022.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Eagle Bay Advisors's 13F filing for Q1 2023, filed 24 Apr 2023.